Results 191 to 200 of about 14,971,001 (334)

Epidemiology and outcome of zygomycosis: a review of 929 reported cases.

Clinical Infectious Diseases, 2005
M. Roden, T. Zaoutis, Wendy L. Buchanan, T. Knudsen, Tatyana A Sarkisova, R. Schaufele, M. Sein, Tin Sein., C. Chiou, Jaclyn H. Chu, D. Kontoyiannis, T. Walsh   +11 more
semanticscholar   +1 more source

Aggressive prostate cancer is associated with pericyte dysfunction

Molecular Oncology, EarlyView.
Tumor‐produced TGF‐β drives pericyte dysfunction in prostate cancer. This dysfunction is characterized by downregulation of some canonical pericyte markers (i.e., DES, CSPG4, and ACTA2) while maintaining the expression of others (i.e., PDGFRB, NOTCH3, and RGS5).
Anabel Martinez‐Romero, Ane Martinez‐Larrinaga, Joaquim Grego‐Bessa, Saioa Garcia‐Longarte, Hielke van Splunder, Ianire Astobiza, Amaia Ercilla, Laura Bozal‐Basterra, Isabel Mendizabal, Pilar Villacampa, Arkaitz Carracedo, Mariona Graupera   +11 more
wiley   +1 more source

Pitfalls of Using Negative Control Outcomes in Environmental Epidemiology. [PDF]

Curr Environ Health Rep
McBrien H, Rudolph KE, Casey JA, Mayeda ER, Inose S, Kioumourtzoglou MA.   +5 more
europepmc   +1 more source

Loss of White Matter Microstructural Integrity Is Associated with Adverse Neurological Outcome in Tuberous Sclerosis Complex

, 2011
Jurriaan M. Peters, Mustafa Şahin, Vanessa Vogel‐Farley, Shafali Jeste, Charles A. Nelson, Matthew Gregas, Sanjay P. Prabhu, Benoît Scherrer, Simon K. Warfield   +8 more
openalex   +2 more sources

Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials.

The Lancet Diabetes and Endocrinology, 2019
S. Kristensen, R. Rørth, P. Jhund, K. Docherty, N. Sattar, D. Preiss, L. Køber, M. Petrie, J. McMurray   +8 more
semanticscholar   +1 more source

Tumor and germline testing with next generation sequencing in epithelial ovarian cancer: a prospective paired comparison using an 18‐gene panel

Molecular Oncology, EarlyView.
Genetic testing in epithelial ovarian cancer includes both germline and tumor‐testing. This approach often duplicates resources. The current prospective study assessed the feasibility of tumor‐first multigene testing by comparing tumor tissue with germline testing of peripheral blood using an 18‐gene NGS panel in 106 patients.
Elisabeth Spenard, Cristina Mitric, Melanie Care, Tracy L. Stockley, Raymond H. Kim, Jeanna McCuaig, Blaise Clarke, Laura Ranich, Clare Sheen, Sarah E. Ferguson, Liat Hogen, Taymaa May, Marcus Q. Bernardini   +12 more
wiley   +1 more source

Longitudinal Outcome Evaluations of Interdisciplinary Multimodal Pain Treatment Programs for Patients With Chronic Primary Musculoskeletal Pain: A Living Systematic Review. [PDF]

Eur J Pain
Cnockaert E, Musch K, Elbers S, Köke A, Van Oosterwijck J, Huijnen I, Smeets R.   +6 more
europepmc   +1 more source

The neural crest‐associated gene ERRFI1 is involved in melanoma progression and resistance toward targeted therapy

Molecular Oncology, EarlyView.
ERRFI1, a neural crest (NC)‐associated gene, was upregulated in melanoma and negatively correlated with the expression of melanocytic differentiation markers and the susceptibility of melanoma cells toward BRAF inhibitors (BRAFi). Knocking down ERRFI1 significantly increased the sensitivity of melanoma cells to BRAFi.
Nina Wang, Qian Sun, Daniel Novak, Lei Zhu, Juliane Poelchen, Tamara Steinfass, Yiman Wang, Viktor Umansky, Jochen Utikal   +8 more
wiley   +1 more source

Navigating decision space: Causal structure improves performance in a branching choice task. [PDF]

PLoS One
Arslan A, Kominsky JF.
europepmc   +1 more source

Improving Treatment Outcome for Children with HIV [PDF]

, 2011
Calmy, Alexandra L, Ford, Nathan
core   +2 more sources